Company overview

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
Founded in 2012
New York, New York, USA
64% recommend to a friend
89% positive business outlook

Salaries

Typical salary range

$18 – $25

HOUR

Help build salary transparency at Axsome Therapeutics, Inc.

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

2 open now

Funding

Total funding

$1B

Last raise

$570M

Post IPO Debt, 10 months ago

Funding history

May 2025

Post IPO Debt Axsome Therapeutics · $570M

Jun 2023

Post IPO Equity Axsome Therapeutics · $225M

Dec 2019

Post IPO Equity Axsome Therapeutics · $200M

May 2015

Venture Round Axsome Therapeutics · $2.5M

Jan 2015

Debt Financing Axsome Therapeutics · $1.3M

Oct 2014

Debt Financing Axsome Therapeutics · $2M

Audience

LinkedIn followers

Follower count and growth

Total followers

38.3K

12-mo growth

+35.3%

Monthly growth

+3.2%

News

Links